LB Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -42.6% | +0.0% | +1,566.4% | -2.4% | +25.7% | -8.1% | |
| – | – | – | – | -48.8% | +0.0% | +2,040.6% | -2.5% | +26.1% | -8.7% | |
| – | – | – | – | -38.1% | +0.0% | +1,796.3% | -7.3% | +28.2% | -11.7% | |
| – | – | – | – | – | +0.0% | +2,110.7% | -6.1% | +23.9% | -10.4% | |
| – | – | – | – | -93.1% | +1,289.3% | -91.5% | +10.4% | +27.2% | +98.4% | |
| – | – | – | – | -51.8% | +0.0% | +70.2% | +12.0% | +46.5% | +116.1% | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +15.6% | |
| – | – | – | – | -72.6% | +0.0% | +307.9% | -17.9% | +234.7% | -51.0% | |
| – | – | – | – | – | -1,100.1% | – | -2.9% | +25.7% | -12.2% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +534.0% | +0.0% | -98.9% | +0.0% | +9,947.7% | +0.0% | +11.6% | +6.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.